James Paul Scopa

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Aneta Fergson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James Paul Scopa:

Company Role Class Num Shares Value Price $ Report Date Ownership
Adverum Biotechnologies, Inc. Director Common Stock 0 $0 $4.27 09 Dec 2025 Direct
Aligos Therapeutics, Inc. Director Stock Option (Right to Buy) 5,860 25 Jun 2025 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 0 09 Dec 2025 Direct
DICE Therapeutics, Inc. Director Common Stock 0 $46.50 09 Aug 2023 By Trust
DICE Therapeutics, Inc. Director Common Stock 0 $46.50 09 Aug 2023 Direct
DICE Therapeutics, Inc. Director Stock Option (right to buy) 0 09 Aug 2023 Direct

Insider Reports Filed by James Paul Scopa

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADVM Adverum Biotechnologies, Inc. 09 Dec 2025 9 $0 4 Director 10 Dec 2025, 13:29
ALGS Aligos Therapeutics, Inc. 25 Jun 2025 1 $0 4 Director 26 Jun 2025, 16:30
ADVM Adverum Biotechnologies, Inc. 17 Jun 2025 1 $0 4 Director 20 Jun 2025, 16:26
ALGS Aligos Therapeutics, Inc. 27 Jun 2024 1 $0 4 Director 28 Jun 2024, 16:07
ADVM Adverum Biotechnologies, Inc. 17 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:44
ALGS Aligos Therapeutics, Inc. 27 Feb 2024 2 $0 4 Director 28 Feb 2024, 17:34
ADVM Adverum Biotechnologies, Inc. 07 Feb 2024 1 +$135,000 4 Director 09 Feb 2024, 17:51
ALGS Aligos Therapeutics, Inc. 25 Oct 2023 2 +$150,000 4 Director 27 Oct 2023, 16:13
/report/000120919123045182-scopa-james-paul-2023-08-09 DICE Therapeutics, Inc. 09 Aug 2023 6 $0 4 Director 09 Aug 2023, 16:33
/report/000120919123044546-scopa-james-paul-2023-08-02 DICE Therapeutics, Inc. 02 Aug 2023 2 $0 4 Director 03 Aug 2023, 19:37
ALGS Aligos Therapeutics, Inc. 20 Jul 2023 1 $0 4 Director 21 Jul 2023, 16:11
/report/000120919123042750-scopa-james-paul-2023-07-18 DICE Therapeutics, Inc. 18 Jul 2023 1 $0 4 Director 19 Jul 2023, 16:53
/report/000120919123042235-scopa-james-paul-2023-07-11 DICE Therapeutics, Inc. 11 Jul 2023 1 $0 4 Director 13 Jul 2023, 17:12
ADVM Adverum Biotechnologies, Inc. 09 Jun 2023 1 $0 4 Director 13 Jun 2023, 17:17
/report/000120919123026618-scopa-james-paul-2023-05-01 DICE Therapeutics, Inc. 01 May 2023 2 $0 4 Director 02 May 2023, 17:49
/report/000120919123020299-scopa-james-paul-2022-10-24 DICE Therapeutics, Inc. 24 Oct 2022 3 -$290,500 4 Director 21 Mar 2023, 16:47
ALGS Aligos Therapeutics, Inc. 23 Jun 2022 1 $0 4 Director 27 Jun 2022, 16:13
ADVM Adverum Biotechnologies, Inc. 10 Jun 2022 1 $0 4 Director 14 Jun 2022, 16:22
/report/000120919122035071-scopa-james-paul-2022-06-07 DICE Therapeutics, Inc. 07 Jun 2022 1 $0 4 Director 08 Jun 2022, 16:53
/report/000120919122008948-scopa-james-paul-2021-12-31 DICE Therapeutics, Inc. 31 Dec 2021 2 $0 5 Director 11 Feb 2022, 16:33
ADVM Adverum Biotechnologies, Inc. 15 Nov 2021 1 -$109,000 4 Director 17 Nov 2021, 15:38
/report/000120919121056526-scopa-james-paul-2021-09-14 DICE Therapeutics, Inc. 14 Sep 2021 5 +$102,000 4 Director 16 Sep 2021, 21:30
/report/000120919121056066-scopa-james-paul-2021-09-14 DICE Therapeutics, Inc. 14 Sep 2021 0 $0 3 Director 14 Sep 2021, 19:34
ADVM Adverum Biotechnologies, Inc. 12 May 2021 1 $0 4 Director 14 May 2021, 20:03